Clinical Trial Update: Natalizumab De-escalation With Interferon Beta-1b [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating de-escalation of natalizumab with interferon beta-1b in relapse-remitting multiple sclerosis; the study completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Interferon beta-1b (Interferon beta-1b)
• Natalizumab (natalizumab)

Snippet

Sponsor: Claudio Gobbi | Conditions: Relapsing-remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2014-04-17